Glimepiride - CAS# 93479-97-1 178 Smiles: NCCCNCCSP(O)(O)=O

Smiles: NCCCNCCSP(O)(O)=O

and U266 xenografts with ED50 of 20 mg/kg and 2 mg/kg for 8226 and OPM-2

GW501516 treatment enhances running endurance and the proportion of succinate dehydrogenase (SDH)-positive muscle fibres in both trained and untrained mice

43(9):1871-1879

Glimepiride - CAS# 93479-97-1 178 Smiles: NCCCNCCSP(O)(O)=OGlimepiride is a third generation sulfonylurea compound, which increases the release of insulin from pancreatic beta cells. In addition, glimepiride increases the activity of intracellular insulin receptors. Glimepiride increases osteoblast proliferation and differentiation, which is thought to be related to its ability to activate the PI3K and Akt pathway. Furthermore, Glimepiride enhances intrinsic peroxisome proliferator activated receptor